Nunn Jason Raleigh Insider Trades

Insider Trading History

Track insider trading activity for Nunn Jason Raleigh. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $374k 18,500 shares
Last Trade
Jun 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 18,500 shares
$18.71
$20.20
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $23.7M 1,173,395 shares
Last Trade
Oct 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.75M 63,158 shares
$27.76
$20.20
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.53M 187,475 shares
$8.16
$8.16
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $374k 18,500 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 18,500 shares
$11.94
$20.20
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $510k 62,500 shares
Last Trade
Apr 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 62,500 shares
$7.98
$8.16
Trevena
Trevena TRVN
Director
Holding Value $152 13,700 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 13,700 shares
$10.00
$0.01
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $490k 60,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 60,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $245k 30,000 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.3k 30,000 shares
$2.01
$8.16
Addex Therapeutics
Addex Therapeutics ADXN
Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2024 Sale
$393k 50,000 shares
$7.85
$6.45
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $122k 15,000 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4k 15,000 shares
$1.36
$8.16
Trevena
Trevena TRVN
Director
Holding Value $152 13,700 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$356k 13,700 shares
$26.00
$0.01
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $245k 30,000 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.5k 30,000 shares
$1.45
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $734k 90,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 90,000 shares
$2.67
$8.16
Trevena
Trevena TRVN
Director
Holding Value $1.11k 100,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9M 100,000 shares
$268.75
$0.01
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $326k 40,000 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 40,000 shares
$9.88
$8.16
Trevena
Trevena TRVN
Director
Holding Value $761 68,577 shares
Last Trade
May 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.6M 68,577 shares
$1,087.50
$0.01
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $190k 23,250 shares
Last Trade
Jun 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 23,250 shares
$8.83
$8.16
Trevena
Trevena TRVN
Director
Holding Value $712 64,103 shares
Last Trade
May 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.1M 64,103 shares
$656.25
$0.01
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $379k 46,500 shares
Last Trade
Oct 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$299k 46,500 shares
$6.44
$8.16
Journey Medical
Journey Medical DERM
Director
Holding Value $0 0 shares
Last Trade
Jun 12, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$6.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up